CFOs Weigh In as COP29, Trump’s Election Fuel Climate Debate
Plus, AstraZeneca’s Aradhana Sarin discusses margins, the Inflation Reduction Act and obesity drugs.
As global leaders meet to discuss efforts to address climate change, CFOs, too, face tough decisions around sustainability. Photo credit: Bloomberg
This article is for subscribers only.
Welcome to CFO Briefing, a newsletter devoted to corporate finance and what leaders need to know. This week, I take a closer look at companies’ climate initiatives in light of COP29 and Trump’s return and talk to AstraZeneca CFO Aradhana Sarin.
But first, here’s some other news that caught my eye: